CRABP2 is extensively connected in the development of neuroblastoma, Wilms tumor, head and neck squamous-cell carcinoma (HNSCC), and non-small cell lung cancer (NSCLC). Here, CRABP2 is linked to head and neck squamous cell carcinoma.